Search Results - "Petrova, Zaritza O."

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma by Berko, Esther R., Witek, Gabriela M., Matkar, Smita, Petrova, Zaritza O., Wu, Megan A., Smith, Courtney M., Daniels, Alex, Kalna, Joshua, Kennedy, Annie, Gostuski, Ivan, Casey, Colleen, Krytska, Kateryna, Gerelus, Mark, Pavlick, Dean, Ghazarian, Susan, Park, Julie R., Marachelian, Araz, Maris, John M., Goldsmith, Kelly C., Radhakrishnan, Ravi, Lemmon, Mark A., Mossé, Yaël P.

“…Activating point mutations in Anaplastic Lymphoma Kinase (ALK ) have positioned ALK as the only mutated oncogene tractable for targeted therapy in…”
Get full text

On the nature of mycobacteriophage diversity and host preference by Jacobs-Sera, Deborah, Marinelli, Laura J, Bowman, Charles, Broussard, Gregory W, Guerrero Bustamante, Carlos, Boyle, Michelle M, Petrova, Zaritza O, Dedrick, Rebekah M, Pope, Welkin H, Science Education Alliance Phage Hunters Advancing Genomics and Evolutionary Science (SEA-PHAGES) program, Modlin, Robert L, Hendrix, Roger W, Hatfull, Graham F

“…Abstract The complete genome sequences of over 220 mycobacteriophages reveal them to be highly diverse, with numerous types sharing little or no nucleotide…”
Get full text

Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes by Mudumbi, Krishna C., Burns, Eric A., Schodt, David J., Petrova, Zaritza O., Kiyatkin, Anatoly, Kim, Lucy W., Mangiacapre, Emma M., Ortiz-Caraveo, Irais, Rivera Ortiz, Hector, Hu, Chun, Ashtekar, Kumar D., Lidke, Keith A., Lidke, Diane S., Lemmon, Mark A.

“…The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase with important roles in many cellular processes as well as in cancer and other…”
Get full text

A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition by Lenchner, Daniel S., Petrova, Zaritza O., Hunihan, Lisa, Ashtekar, Kumar D., Walther, Zenta, Wilson, Frederick H.

“…EGFR tyrosine kinase inhibitors (TKIs) have transformed the treatment of EGFR-mutated non-small cell lung carcinoma (NSCLC); however, therapeutic resistance…”
Get full text

Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography by Chan, Albert H., Lee, Won-Gil, Spasov, Krasimir A., Cisneros, José A., Kudalkar, Shalley N., Petrova, Zaritza O., Buckingham, Amanda B., Anderson, Karen S., Jorgensen, William L.

“…Development of resistance remains a major challenge for drugs to treat HIV-1 infections, including those targeting the essential viral polymerase, HIV-1…”
Get full text

Mycobacteriophage-repressor-mediated immunity as a selectable genetic marker: Adephagia and BPs repressor selection by Petrova, Zaritza O, Broussard, Gregory W, Hatfull, Graham F

“…Mycobacteriophages provide an abundance of systems for use in mycobacterial genetics, including manipulation of Mycobacterium tuberculosis. Because of the…”
Get full text